Dietmar Springer

810 total citations
18 papers, 668 citations indexed

About

Dietmar Springer is a scholar working on Pharmacology, Oncology and Toxicology. According to data from OpenAlex, Dietmar Springer has authored 18 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 5 papers in Oncology and 5 papers in Toxicology. Recurrent topics in Dietmar Springer's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Dietmar Springer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Dietmar Springer collaborates with scholars based in Germany and United States. Dietmar Springer's co-authors include Hans H. Maurer, Giselher Fritschi, Roland F. Staack, Thomas Kræmer, C.Y.W. ANG, Frank T. Peters, Liane D. Paul, Denis S. Theobald, James L. Merdink and R.D. Stenner and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Biochemical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Dietmar Springer

18 papers receiving 641 citations

Peers

Dietmar Springer
Giselher Fritschi Germany
Andrea E. Schwaninger Germany
Denis S. Theobald Germany
Г. М. Родченков Russia
Amira S. Wanas Egypt
Tim Sobolevsky United States
Monica R. Brzezinski United States
Takako Seto Japan
Maiko Kawamura Japan
Naresh C. Jain United States
Giselher Fritschi Germany
Dietmar Springer
Citations per year, relative to Dietmar Springer Dietmar Springer (= 1×) peers Giselher Fritschi

Countries citing papers authored by Dietmar Springer

Since Specialization
Citations

This map shows the geographic impact of Dietmar Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietmar Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietmar Springer more than expected).

Fields of papers citing papers by Dietmar Springer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dietmar Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietmar Springer. The network helps show where Dietmar Springer may publish in the future.

Co-authorship network of co-authors of Dietmar Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Dietmar Springer. A scholar is included among the top collaborators of Dietmar Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dietmar Springer. Dietmar Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zimmermann, Thomas, et al.. (2012). Rapid resolution liquid chromatography for monitoring the quality of stockpiled atropine preparations for injection. Drug Testing and Analysis. 4(3-4). 222–228. 4 indexed citations
2.
Berg, Stefan, et al.. (2010). Assessment of the Next Generation Mobile Network candidate technologies. 1–7. 2 indexed citations
3.
Maurer, Hans H., Thomas Kræmer, Dietmar Springer, & Roland F. Staack. (2004). Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types. Therapeutic Drug Monitoring. 26(2). 127–131. 107 indexed citations
4.
Kræmer, Thomas, Frank T. Peters, Liane D. Paul, et al.. (2004). Fenproporex N-dealkylation to amphetamine—enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats. Biochemical Pharmacology. 68(5). 947–957. 14 indexed citations
5.
Staack, Roland F., Denis S. Theobald, Liane D. Paul, et al.. (2004). In vivometabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. Xenobiotica. 34(2). 179–192. 28 indexed citations
6.
Staack, Roland F., Denis S. Theobald, Liane D. Paul, et al.. (2004). IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE. Drug Metabolism and Disposition. 32(4). 379–381. 29 indexed citations
7.
Staack, Roland F., Dietmar Springer, Denis S. Theobald, & Hans H. Maurer. (2004). [New designer drugs. Pharmacology, toxicology and metabolism].. PubMed. 27(12). 408–13. 2 indexed citations
8.
Springer, Dietmar, Giselher Fritschi, & Hans H. Maurer. (2003). Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography–mass spectrometry. Journal of Chromatography B. 793(2). 377–388. 54 indexed citations
9.
Springer, Dietmar, Giselher Fritschi, & Hans H. Maurer. (2003). Metabolism and toxicological detection of the new designer drug 4′-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography–mass spectrometry. Journal of Chromatography B. 793(2). 331–342. 63 indexed citations
10.
Springer, Dietmar, Frank T. Peters, Giselher Fritschi, & Hans H. Maurer. (2003). New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography–mass spectrometry. Journal of Chromatography B. 789(1). 79–91. 54 indexed citations
11.
12.
Springer, Dietmar, Liane D. Paul, Roland F. Staack, Thomas Kræmer, & Hans H. Maurer. (2003). IDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 31(8). 979–982. 22 indexed citations
13.
Springer, Dietmar, Roland F. Staack, Liane D. Paul, Thomas Kræmer, & Hans H. Maurer. (2003). Identification of cytochrome P450 enzymes involved in the metabolism of 4′-methoxy-α-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes. Xenobiotica. 33(10). 989–998. 20 indexed citations
14.
Staack, Roland F., Liane D. Paul, Dietmar Springer, Thomas Kræmer, & Hans H. Maurer. (2003). Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). Biochemical Pharmacology. 67(2). 235–244. 29 indexed citations
15.
Springer, Dietmar, Frank T. Peters, Giselher Fritschi, & Hans H. Maurer. (2002). Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography–mass spectrometry. Journal of Chromatography B. 773(1). 25–33. 51 indexed citations
16.
ANG, C.Y.W., et al.. (2000). Optimization of Extraction Conditions for Active Components inHypericum perforatumUsing Response Surface Methodology. Journal of Agricultural and Food Chemistry. 48(8). 3364–3371. 93 indexed citations
17.
ANG, C.Y.W., et al.. (2000). Optimization of Extraction Conditions for Active Components in Hypericum perforatum Using Response Surface Methodology. Journal of Agricultural and Food Chemistry. 48(11). 5788–5788. 3 indexed citations
18.
Stenner, R.D., James L. Merdink, D.K. Stevens, Dietmar Springer, & Richard J. Bull. (1997). Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene.. PubMed. 25(5). 529–35. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giselher Fritschi Breakdown of academic impact, for papers by Andrea E. Schwaninger Breakdown of academic impact, for papers by Denis S. Theobald Breakdown of academic impact, for papers by Г. М. Родченков Breakdown of academic impact, for papers by Amira S. Wanas Breakdown of academic impact, for papers by Tim Sobolevsky Breakdown of academic impact, for papers by Monica R. Brzezinski Breakdown of academic impact, for papers by Takako Seto Breakdown of academic impact, for papers by Maiko Kawamura Breakdown of academic impact, for papers by Naresh C. Jain
Rankless by CCL
2026